2000
DOI: 10.1177/00220345000790030301
|View full text |Cite
|
Sign up to set email alerts
|

Development and Characterization of a Tissue-engineered Human Oral Mucosa Equivalent Produced in a Serum-free Culture System

Abstract: A problem maxillofacial surgeons face is a lack of sufficient autogenous oral mucosa for reconstruction of the oral cavity. Split-thickness or oral mucosa grafts require more than one surgical procedure and can result in donor site morbidity. Skin has disadvantages of adnexal structures and a different keratinization pattern than oral mucosa. In this study, we successfully assembled, ex vivo, a human oral mucosa equivalent, consisting of epidermal and dermal components, in a defined, essential-fatty-acid-defic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
93
0
1

Year Published

2002
2002
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 113 publications
(98 citation statements)
references
References 33 publications
4
93
0
1
Order By: Relevance
“…18 Briefly, human oral keratinocytes were generated and amplified from trypsinized discarded human oral mucosa obtained by routine dentoalveolar surgical procedures. AlloDerm (LifeCell) was rehydrated in phosphate-buffered saline (PBS) 1 h before use.…”
Section: Production Of Ex Vivo-produced Oral Mucosa Equivalentmentioning
confidence: 99%
See 2 more Smart Citations
“…18 Briefly, human oral keratinocytes were generated and amplified from trypsinized discarded human oral mucosa obtained by routine dentoalveolar surgical procedures. AlloDerm (LifeCell) was rehydrated in phosphate-buffered saline (PBS) 1 h before use.…”
Section: Production Of Ex Vivo-produced Oral Mucosa Equivalentmentioning
confidence: 99%
“…[13][14][15][16][17] We reported on the characteristics of an ex vivo-produced oral mucosa equivalent (EVPOME) utilizing AlloDerm in a serum-free, defined medium, without an irradiated xenogeneic feeder layer. 18 In preparation for human clinical trials it was necessary to optimize the culture protocol for the in vivo grafting of EVPOME. In this investigation, we evaluated EVPOME by transplanting it into immunologically compromised (SCID, severe combined immunodeficient) mice, using the technique of Barrandon et al, 19 which places the graft into a subcutaneous dorsal skin pouch of athymic mice.…”
Section: Introduction Smentioning
confidence: 99%
See 1 more Smart Citation
“…36 Oral tissues can be generated by harvesting cells from the oral cavity, expanding them, and growing them in a 3D tissue before engraftment. 37,38 Recently, 3D, skin-like tissues have been approved for clinical use in the treatment of periodontal disease. 39 Levenberg et al first established proof-ofconcept that ectodermal and mesenchymal cells differentiated from hESCs could assemble into tissues displaying in vivo-like features and could integrate into the host vasculature.…”
Section: Tissue Engineering Of Complex Tissues Using Ipsc-derived Cellsmentioning
confidence: 99%
“…Tissue was grown until the epithelial cells reached confluence. To mimic the keratinized palatal mucosa tissue, EHOM were then raised to an air-liquid interface for 5 more days to allow the epithelium to stratify [27,28]. Following this process, as we have shown previously, the EHOM was a well-organized and stratified tissue in which epithelial cells expressed proliferating keratins such as Ki-67, K14, and K19 and also differentiating keratin K10.…”
Section: Preparation Of Engineered Human Oral Mucosamentioning
confidence: 99%